[1] |
Swallow CJ, Strauss DC, Bonvalot S, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group[J]. Ann Surg Oncol, 2021, 28(12):7873-7888.
doi: 10.1245/s10434-021-09654-z
pmid: 33852100
|
[2] |
中华医学会肿瘤学分会, 中华医学会杂志社, 中国医师协会肛肠医师分会腹膜后疾病专业委员会, 等. 中国腹膜后肿瘤诊治专家共识(2019版)[J]. 中华肿瘤杂志, 2019, 41(10):728-733.
|
[3] |
Rajiah P, Sinha R, Cuevas C, et al. Imaging of uncommon retroperitoneal masses[J]. Radiographics, 2011, 31(4):949-976.
doi: 10.1148/rg.314095132
pmid: 21768233
|
[4] |
Gupta P, Potti TA, Wuertzer SD, et al. Spectrum of fat-containing soft-tissue masses at MR imaging: the common, the uncommon, the characteristic, and the sometimes confusing[J]. Radiographics, 2016, 36(3):753-766.
doi: 10.1148/rg.2016150133
pmid: 27163592
|
[5] |
Shaaban AM, Rezvani M, Tubay M, et al. Fat-containing retroperitoneal lesions: imaging characteristics, localization, and differential diagnosis[J]. Radiographics, 2016, 36(3):710-734.
doi: 10.1148/rg.2016150149
pmid: 27163589
|
[6] |
Marko J, Wolfman DJ. Retroperitoneal leiomyosarcoma from the radiologic pathology archives[J]. Radiographics, 2018, 38(5):1403-1420.
doi: 10.1148/rg.2018180006
pmid: 30207936
|
[7] |
Sun J, Yu XR, Shi BB, et al. CT features of retroperitoneal solitary fibrous tumor: report of three cases and review of the literature[J]. World J Surg Oncol, 2014, 12:324.
doi: 10.1186/1477-7819-12-324
pmid: 25351104
|
[8] |
Keraliya AR, Tirumani SH, Shinagare AB, et al. Solitary fibrous tumors: 2016 imaging update[J]. Radiol Clin North Am, 2016, 54(3):565-579.
doi: 10.1016/j.rcl.2015.12.006
URL
|
[9] |
Petscavage-Thomas JM, Walker EA, Logie CI, et al. Soft-tissue myxomatous lesions: review of salient imaging features with pathologic comparison[J]. Radiographics, 2014, 34(4):964-980.
doi: 10.1148/rg.344130110
pmid: 25019435
|
[10] |
Lefkowitz RA, Landa J, Hwang S, et al. Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging[J]. Skeletal Radiol, 2013, 42(6):809-818.
doi: 10.1007/s00256-012-1563-6
pmid: 23318907
|
[11] |
Banks KP. The target sign: extremity[J]. Radiology, 2005, 234(3):899-900.
doi: 10.1148/radiol.2343030946
pmid: 15734940
|
[12] |
Stramare R, Beltrame V, Gazzola M, et al. Imaging of soft-tissue tumors[J]. J Magn Reson Imaging, 2013, 37(4):791-804.
doi: 10.1002/jmri.23791
pmid: 22972755
|
[13] |
Pilavaki M, Chourmouzi D, Kiziridou A, et al. Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review[J]. Eur J Radiol, 2004, 52(3):229-239.
doi: 10.1016/j.ejrad.2003.12.001
pmid: 15544900
|
[14] |
Rha SE, Byun JY, Jung SE, et al. Neurogenic tumors in the abdomen: tumor types and imaging characteristics[J]. Radiographics, 2003, 23(1):29-43.
pmid: 12533638
|
[15] |
Zhang Y, Nishimura H, Kato S, et al. MRI of ganglioneuroma: histologic correlation study[J]. J Comput Assist Tomogr, 2001, 25(4):617-623.
pmid: 11473195
|
[16] |
Lee KY, Oh YW, Noh HJ, et al. Extraadrenal paragangliomas of the body: imaging features[J]. Am J Roentgenol, 2006, 187(2):492-504.
doi: 10.2214/AJR.05.0370
pmid: 16861555
|
[17] |
Janssen I, Chen CC, Millo CM, et al. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(10):1784-1791.
doi: 10.1007/s00259-016-3357-x
URL
|
[18] |
Kitajima K, Kono A, Konishi J, et al. 18F-FDG-PET/CT findings of retroperitoneal tumors: a pictorial essay[J]. Jpn J Radiol, 2013, 31(5):301-309.
doi: 10.1007/s11604-013-0192-x
URL
|
[19] |
Atri M, Zhang Z, Dehdashti F, et al. Utility of PET/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671/GOG 0233 trial[J]. Radiology, 2017, 283(2):450-459.
doi: 10.1148/radiol.2016160200
pmid: 28051912
|
[20] |
Subramaniam S, Callahan J, Bressel M, et al. The role of 18F-FDG PET/CT in retroperitoneal sarcomas—a multicenter retrospective study[J]. J Surg Oncol, 2021, 123(4):1081-1087.
doi: 10.1002/jso.26379
pmid: 33444466
|
[21] |
Fernando A, Pattison J, Horsfield C, et al. 18F-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study[J]. Eur Urol, 2017, 71(6):926-933.
doi: S0302-2838(16)30760-6
pmid: 27876167
|
[22] |
Lim CH, Seok HY, Hyun SH, et al. Evaluation of a diagnostic 18F-FDG PET/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses[J]. Clin Radiol, 2019, 74(3):207-215.
doi: S0009-9260(18)30623-8
pmid: 30638733
|
[23] |
Costa LB, Queiroz MA, Barbosa FG, et al. Reassessing patterns of response to immunotherapy with PET: from morphology to metabolism[J]. Radiographics, 2021, 41(1):120-143.
doi: 10.1148/rg.2021200093
pmid: 33275541
|
[24] |
谢琉嘉, 徐亚丹, 闻捷先, 等. 超声造影引导下经皮腹膜后占位性病变穿刺活检的价值[J]. 肿瘤影像学, 2019, 28(6):365-370.
|
[25] |
Leahy S, Fang AM, Banks C, et al. Intravascular ultrasound for the evaluation and management of retroperitoneal, genitourinary malignancies[J]. Curr Urol Rep, 2022, 23(5):67-73.
doi: 10.1007/s11934-022-01092-y
pmid: 35286591
|
[26] |
Hannesson PH, Lundstedt C, Dawiskiba S, et al. Transhepatic intravascular ultrasound for evaluation of portal venous involvement in patients with cancer of the pancreatic head region[J]. Eur Radiol, 2002, 12(5):1150-1154.
pmid: 11976861
|
[27] |
王成刚, 龚高全. 介入技术在腹膜后肿瘤临床诊疗中的应用进展[J]. 中国临床医学, 2021, 28(2):323-327.
|
[28] |
彭梦凡, 李玉燕, 齐清华, 等. 超声引导射频消融治疗腹膜后肿瘤的临床价值[J]. 中华肿瘤杂志, 2022, 44(5):442-445.
|